ABBOTT INDIA DECLARES DIVIDEND OF ₹410, Q4 NET PROFIT RISES 24%

Drug major Abbott India Ltd on Thursday (May 9) reported a 24.1% year-on-year (YoY) jump in net profit at ₹287.1 crore for the fourth quarter that ended March 31, 2024.

In the corresponding quarter, Abbott India posted a net profit of ₹231.4 crore, the company said in a regulatory filing. The company's revenue from operations increased 7.1% to ₹1,438.6 crore against ₹1,343.1 crore in the corresponding period of the preceding fiscal.

At the operating level, EBITDA rose 17.6% to ₹329.5 crore in the fourth quarter of this fiscal over ₹280.1 crore in the corresponding period in the previous fiscal.

Also Read: Tata Power Q4 Results | Net profit jumps 15% to ₹895 crore, declares dividend of ₹2

The EBITDA margin stood at 22.9% in the reporting quarter compared to 20.9% in the year-ago period. EBITDA is earnings before interest, tax, depreciation, and amortisation.

The board of directors has recommended payment of a final dividend of ₹410 per equity share of ₹10 each for the year ended March 31, 2024, subject to the approval of the shareholders at the ensuing 80th annual general meeting of the company.

The company has fixed Friday, July 19, 2024, as the record date for determining entitlement of members to the final dividend for the financial year ended March 31, 2024.

Also Read: IRB Infrastructure Q4 Results | Net profit surges 45%, dividend declared

The results came after the close of the market hours. Shares of Abbott India Ltd ended at ₹25,606.55, down by ₹ 339.05, or 1.31%, on the BSE.

2024-05-09T14:59:11Z dg43tfdfdgfd